Factors associated with multiple medication use in different age groups

The Annals of Pharmacotherapy
Janne MoenLena Ring

Abstract

Multiple medicine use among elderly persons is likely to be the result of treatment regimens developed over a long period of time. By learning more about how multiple medication use develops, the quality of prescribing may be improved across the adult lifespan. To describe patterns of multiple medicine use in the general Swedish population and its association with sociodemographic, lifestyle, and health status factors. Data from a cross-sectional population health survey collected during 2001-2005 from 2816 randomly selected Swedish residents (age 30-75 y; response rate 76%) were analyzed. Multiple medicine use was restricted to prescription drugs and defined as the 75th percentile; that is, the 25% of the study group using the highest number of drugs per individual. Seventy-one percent of the respondents used some kind of drug, 51.5% used one or more prescription drug, 38.4% used one or more over-the-counter (OTC) medication, and 8.3% used one or more herbal preparation. The cutoff amounts defining multiple medicine use were: 2 or more medications for 30- to 49-year-olds, 3 or more for 50- to 64-year-olds, and 5 or more for 65- to 75-year-olds. No association between use of multiple medicines and use of OTC drugs or herbal pre...Continue Reading

References

Oct 1, 1989·Scandinavian Journal of Primary Health Care·D Isacson, B Haglund
Sep 1, 1985·Journal of Health and Social Behavior·L M Verbrugge
Jul 29, 1998·European Journal of Clinical Pharmacology·L BjerrumJ Kragstrup
Aug 24, 1999·European Journal of Clinical Pharmacology·H F ThomasD K Luscombe
Jun 14, 2000·Family Practice·L VeehofB M Jong
Jul 3, 2002·Annals of Internal Medicine·Cary P GrossHarlan M Krumholz
Oct 18, 2002·Journal of Clinical Epidemiology·Tarja LinjakumpuRaimo Isoaho
Jun 27, 2003·The New England Journal of Medicine·Elizabeth A McGlynnEve A Kerr
Jul 17, 2003·Journal of the American Academy of Nurse Practitioners·Maryanne Crowther
Jul 24, 2004·Journal of the American Geriatrics Society·Terry S FieldDavid W Bates
Nov 10, 2004·Pharmacoepidemiology and Drug Safety·Ahmad Al-Windi
Apr 12, 2005·Journal of the American Academy of Nurse Practitioners·Maryann M Fulton, Elizabeth Riley Allen
Mar 3, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·David V EspinoKyriakos Markides
Mar 21, 2006·Research and Theory for Nursing Practice·Marjolein J van VlietMia S H Duijnstee
Aug 31, 2006·British Journal of Clinical Pharmacology·Kirsten K ViktilAasmund Reikvam
Jan 9, 2008·European Journal of Clinical Pharmacology·Shaojun ShiUlrich Klotz
Jan 11, 2008·International Journal of Clinical Pharmacology and Therapeutics·S I HaiderJ Fastbom
Jan 23, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M NyholmU Lindblad
May 9, 2008·The European Journal of General Practice·Lars BjerrumGert Petersen
Feb 11, 2009·International Journal of Clinical Pharmacology and Therapeutics·S HarderF M Gerlach

❮ Previous
Next ❯

Citations

May 6, 2010·International Journal for Equity in Health·Ferran DabanCarme Borrell
Nov 10, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Frits M E FranssenEmiel F M Wouters
Feb 9, 2012·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Carrie A TruittFrank LoVecchio
Jun 8, 2012·International Journal of Clinical Pharmacy·Stephen R CarterTimothy F Chen
Nov 20, 2012·Journal of Nutrition in Gerontology and Geriatrics·Roschelle Heuberger
May 25, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·H Knopf, D Grams
Sep 10, 2013·Geriatric Nursing·Tatjana GazibaraTatjana Pekmezovic
Mar 25, 2015·The International Journal of Pharmacy Practice·Anette Vik MamenElse-Lydia Toverud
Jan 26, 2011·Pharmacoepidemiology and Drug Safety·Alessandro NobiliLuca Merlino
Jun 7, 2013·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Stephen R CarterTimothy F Chen
Jul 11, 2012·The International Journal of Pharmacy Practice·Stephen R CarterLesley White
Feb 26, 2013·Patient Education and Counseling·Stephen R CarterTimothy F Chen
May 20, 2015·Journal of Research in Pharmacy Practice·Negar GolchinSharon B Meropol
Nov 5, 2013·Best Practice & Research. Clinical Gastroenterology·Louisa G Gordon, George C Mayne
Jun 1, 2016·International Journal of Clinical Pharmacy·Lillan Mo AndreassenJames Antony Desborough
Aug 1, 2016·Emergency Medicine Clinics of North America·Katherine Louise Welker, Mark B Mycyk
Jul 31, 2013·Chronic Illness·Gemmae M FixBarbara G Bokhour
Aug 24, 2017·The International Journal of Pharmacy Practice·Gracia NiclósVicent Rodilla
Aug 11, 2017·The International Journal of Pharmacy Practice·Gracia NiclósVicent Rodilla
Feb 1, 2011·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Rupert A Payne, Anthony J Avery
Mar 6, 2019·European Journal of Clinical Pharmacology·Raquel MerinoRosa Terré
May 31, 2012·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Louisa G GordonUNKNOWN Australian Cancer Study Clinical Follow-Up Study Group
Feb 24, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·David Vivas-ConsueloPablo Mendez-Valera
Jul 9, 2020·Revista brasileira de epidemiologia = Brazilian journal of epidemiology·Isabella Ribeiro SilvaRoberta Carvalho de Figueiredo
Mar 17, 2018·Journal of Pharmacokinetics and Pharmacodynamics·Barbara Wiśniowska, Sebastian Polak
Dec 24, 2018·Journal of the American Geriatrics Society·Jonas W WastessonKristina Johnell
Nov 24, 2011·Current Opinion in Clinical Nutrition and Metabolic Care·Johanna JyrkkäEija Lönnroos
Jul 3, 2021·Pharmacoepidemiology and Drug Safety·Johan Van der HeydenOlivier Bruyère

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.